On 12 August 2014
Glaxosmithkline Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2014, to consider amongst other things, approval of unaudited financial results for the quarter April - June 2014 (Q2) and half-year January - June 2014.Powered by Capital Market - Live News